US EditionPublished • loading... • Updated
Curewell Capital Takes Majority Stake in Wilmington PharmaTech to Drive Expansion
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Curewell Capital Takes Majority Stake in Wilmington PharmaTech to Drive Expansion
NEWARK, DE — Wilmington PharmaTech (WPT), a U.S.-based manufacturer of small molecule active pharmaceutical ingredients (API), announced that Los Angeles–based private equity firm Curewell Capital has made a majority investment in the company. The deal aims to accelerate WPT’s expansion and strengthen domestic pharmaceutical manufacturing capabilities. Hui-Yin “Harry” Li, Ph.D., founder and CEO of Wilmington PharmaTech, will retain a significant…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
